Receptor antagonist

• Control of glutamate release by complexes of adenosine and cannabinoid receptors (24 Sep 2024)
  
• Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay (03 Sep 2024)
  
• Probing the Conformational Space of the Cannabinoid Receptor 2 and a Systematic Investigation of DNP (02 Sep 2024)
  
• Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor (02 Sep 2024)
  
• Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism (02 Sep 2024)
  
• Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists (02 Sep 2024)
  
• Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptors (02 Sep 2024)
  
• Distinct activation mechanisms regulate subtype selectivity of Cannabinoid receptors (30 Aug 2024)
  
• Understanding the Dynamics of the Structural States of Cannabinoid Receptors and the Role of Different Modulators (28 Aug 2024)
  
• New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 (28 Aug 2024)
  
• Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules (25 Aug 2024)
  
• Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits (25 Aug 2024)
  
• A GPCR-based yeast biosensor for biomedical, biotechnological, and point-of-use cannabinoid determination (25 Aug 2024)
  
• Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death (21 Aug 2024)
  
• Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products (20 Aug 2024)
  
• Cholesterol as a modulator of cannabinoid receptor CB2 signaling (20 Aug 2024)
  
• Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity (20 Aug 2024)
  
• Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors (20 Aug 2024)
  
• Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel (20 Aug 2024)
  
• Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives (19 Aug 2024)
  
• Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System (19 Aug 2024)
  
• Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines (19 Aug 2024)
  
• Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans (18 Aug 2024)
  
• Modulation of breast cancer cell viability by a cannabinoid receptor 2 (18 Aug 2024)
  
• Cannabinoid receptor type-1: breaking the dogmas (18 Aug 2024)
  
• Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes (18 Aug 2024)
  
• N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA rece (13 May 2024)
  
• New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists (05 Sep 2022)
  
• N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors (01 Sep 2022)
  
• Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
  
• The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation (05 Aug 2022)
  
• Involvement of the endocannabinoid system in the inhibition of Sindbis virus replication: a preliminary study - Journal of Cannabis Research (26 Jul 2022)